Contineum Therapeutics (CTNM) Other Gross PP&E Adjustments (2023 - 2025)
Historic Other Gross PP&E Adjustments for Contineum Therapeutics (CTNM) over the last 3 years, with Q3 2025 value amounting to -$4.8 million.
- Contineum Therapeutics' Other Gross PP&E Adjustments fell 235482.23% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.8 million, marking a year-over-year decrease of 235482.23%. This contributed to the annual value of -$2.9 million for FY2024, which is 57491.69% down from last year.
- Contineum Therapeutics' Other Gross PP&E Adjustments amounted to -$4.8 million in Q3 2025, which was down 235482.23% from -$5.2 million recorded in Q2 2025.
- In the past 5 years, Contineum Therapeutics' Other Gross PP&E Adjustments registered a high of $602000.0 during Q4 2023, and its lowest value of -$5.4 million during Q1 2025.
- In the last 3 years, Contineum Therapeutics' Other Gross PP&E Adjustments had a median value of -$2.8 million in 2024 and averaged -$2.6 million.
- The largest annual percentage gain for Contineum Therapeutics' Other Gross PP&E Adjustments in the last 5 years was 9179.21% (2025), contrasted with its biggest fall of 235482.23% (2025).
- Over the past 3 years, Contineum Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $602000.0 in 2023, then plummeted by 574.92% to -$2.9 million in 2024, then tumbled by 69.15% to -$4.8 million in 2025.
- Its last three reported values are -$4.8 million in Q3 2025, -$5.2 million for Q2 2025, and -$5.4 million during Q1 2025.